Dermatology
Promising drug compound for chronic itch identified

Promising drug compound for chronic itch identified

New York: Researchers have identified a new class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition. more

Transplant recipients more likely to develop aggressive melanoma

Transplant recipients more likely to develop aggressive melanoma

Washington: Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins Bloomberg School of Public Health student. more

New combination treatment effective against melanoma skin metastases

New combination treatment effective against melanoma skin metastases

Washington: In findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown. more

Researchers beat untreatable eczema with arthritis drug

Researchers beat untreatable eczema with arthritis drug

Washington: Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia areata. The study is evidence of a potential new era in eczema treatment, they report. more

Ultrasound accelerates skin healing – especially for diabetics and the elderly

Ultrasound accelerates skin healing – especially for diabetics and the elderly

London: Healing times for skin ulcers and bedsores can be reduced by a third with the use of low-intensity ultrasound, scientists from the University of Sheffield and University of Bristol have found. more

New psoriasis drug helps fast improvement

New psoriasis drug helps fast improvement

London (IANS): Offering hope to thousands of people suffering from the psoriasis skin condition, a trial of a new drug has reported quick and extensive improvement of the disease. more

Anti-fungal drug shows promise as potential new cancer treatment

Anti-fungal drug shows promise as potential new cancer treatment

London: A common anti-fungal treatment has joined the ranks of drugs that may be suitable for use in treating cancer, according to research from the Repurposing Drugs in Oncology (ReDO) project published in ecancermedicalscience. more

Blood test for patients on acne medication deemed unnecessary

Blood test for patients on acne medication deemed unnecessary

Washington: A study by researchers at Brigham and Women’s Hospital (BWH) has found that for young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary healthcare expense. more

A study to compare non-ablative fractional laser therapy on different atrophic acne scars

A study to compare non-ablative fractional laser therapy on different atrophic acne scars

New Delhi: Acne today affects most of the teenagers and adults and poses a therapeutic challenge for dermatologists. Acne scars can occur early in acne development and may affect up to 14 per cent of patients with this disease, which can be more serious if there is a delay in the treatment. more

FDA-approved drug restores hair in patients with Alopecia Areata

FDA-approved drug restores hair in patients with Alopecia Areata

New York: Researchers at Columbia University Medical Centre (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients. The results appear in Nature Medicine. more